<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39423874</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2742</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>The Journal of infection</Title><ISOAbbreviation>J Infect</ISOAbbreviation></Journal><ArticleTitle>Evaluating the effect of BCG vaccination for non-specific protection from infection in senior citizens during the COVID-19 pandemic: A randomised clinical trial.</ArticleTitle><Pagination><StartPage>106319</StartPage><MedlinePgn>106319</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jinf.2024.106319</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0163-4453(24)00253-6</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The Bacillus Calmette-Guérin (BCG) vaccine may induce non-specific protection against unrelated infections. We tested the effect of BCG on the risk of infections among Danish senior citizens.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Single-blinded randomised controlled trial including 1676 volunteers &gt;65 years. Participants were randomised 1:1 to BCG or placebo and followed for 12 months. The primary outcome was acute infection leading to medical contact. Secondary outcomes were verified SARS-CoV-2 infection, self-reported respiratory symptoms, and all-cause hospitalisation. Data was analysed using Cox regression models, estimating hazard ratios (HR) with 95% confidence intervals (CI).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of acute infection was 52.1 and 58.2 per 100 person-years for BCG and placebo, respectively (HR=0.89, 95% CI=0.78-1.02). There was no effect of BCG on SARS-CoV-2 infections (0.97, 0.75-1.26) or all-cause hospitalisations (1.10, 0.80-1.50), but BCG was associated with more respiratory symptoms (1.21, 1.10-1.33). BCG reduced the incidence of acute infections among participants &lt;75 years (0.82, 0.70-0.95) but not among those &gt;75 years (1.14, 0.88-1.47). In participants, who were COVID-19 vaccinated before enrolment, BCG was associated with lower incidence of acute infections (0.65, 0.50-0.85).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">BCG did not reduce risk of acute infections among Danish seniors overall, but the effect was modified by age group and COVID-19 vaccination.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov (NCT04542330) and EU Clinical Trials Register (EudraCT number 2020-003904-15). Full trial protocol is available at ClinicalTrials.gov.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">In a randomised clinical trial among Danish senior citizens, BCG vaccination did not reduce the overall risk of acute infection, but BCG was associated with reduced risk in participants &lt;75 years and participants who received COVID-19 vaccines prior to enrolment.</AbstractText><CopyrightInformation>Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Madsen</LastName><ForeName>Anne Marie Rosendahl</ForeName><Initials>AMR</Initials><AffiliationInfo><Affiliation>Bandim Health Project, Open Patient Data Explorative Network (OPEN), Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Danish Institute for Advanced Study, University of Southern Denmark, Odense, Denmark. Electronic address: arosendahl@health.sdu.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gehrt</LastName><ForeName>Lise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Bandim Health Project, Open Patient Data Explorative Network (OPEN), Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Danish Institute for Advanced Study, University of Southern Denmark, Odense, Denmark; Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaltz-Buchholzer</LastName><ForeName>Frederik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Bandim Health Project, Open Patient Data Explorative Network (OPEN), Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Bandim Health Project, INDEPTH Network, 8611004 Bissau, Guinea-Bissau.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Möller</LastName><ForeName>Sören</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research unit OPEN, Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Open Patient Data Explorative Network (OPEN), Odense University Hospital, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christiansen</LastName><ForeName>Rikke</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bandim Health Project, Open Patient Data Explorative Network (OPEN), Department of Clinical Research, University of Southern Denmark, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schellerup</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Bandim Health Project, Open Patient Data Explorative Network (OPEN), Department of Clinical Research, University of Southern Denmark, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norberg</LastName><ForeName>Lene Annette</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of the Elderly and Disabled, Odense Municipality, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krause</LastName><ForeName>Tyra Grove</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease Epidemiology, Statens Serum Institut, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bandim Health Project, Open Patient Data Explorative Network (OPEN), Department of Clinical Research, University of Southern Denmark, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bliddal</LastName><ForeName>Mette</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research unit OPEN, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aaby</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Bandim Health Project, Open Patient Data Explorative Network (OPEN), Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Bandim Health Project, INDEPTH Network, 8611004 Bissau, Guinea-Bissau.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benn</LastName><ForeName>Christine Stabell</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Bandim Health Project, Open Patient Data Explorative Network (OPEN), Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Danish Institute for Advanced Study, University of Southern Denmark, Odense, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04542330</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Infect</MedlineTA><NlmUniqueID>7908424</NlmUniqueID><ISSNLinking>0163-4453</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BCG revaccination</Keyword><Keyword MajorTopicYN="N">BCG vaccine</Keyword><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">Heterologous effects</Keyword><Keyword MajorTopicYN="N">Infectious diseases</Keyword><Keyword MajorTopicYN="N">Non-specific effects of vaccines</Keyword><Keyword MajorTopicYN="N">Randomised controlled trial</Keyword><Keyword MajorTopicYN="N">Senior citizens</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39423874</ArticleId><ArticleId IdType="doi">10.1016/j.jinf.2024.106319</ArticleId><ArticleId IdType="pii">S0163-4453(24)00253-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle>